Jeanniard-Malet Odile, Duché Mathieu, Fabre Alexandre
*Department of Digestive Endoscopy, AP-HM Hôpital de la Timone Adulte †Department of Digestive Endoscopy, Hôpital Européen ‡Department of Digestive Endoscopy, Hôpital Privé Beauregard, Marseille §Department of Paediatric Hepatology and National Referral Centre for Biliary Atresia and Paediatric Radiology, AP-HP Hôpital Bicêtre, Le Kremlin-Bicêtre ||Paris-Sud 11 University, Orsay, France ¶Department of Multidisciplinary Paediatrics, AP-HM Hôpital de la Timone Enfant, Marseille, France.
J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):524-527. doi: 10.1097/MPG.0000000000001453.
Primary prophylaxis in portal hypertension in children is controversial, because there are few studies documenting its efficacy on the risk of bleeding. Twenty-eight centres out of the 38 we contacted returned a completed questionnaire about their clinical practices. More than 75% of the centres use endoscopy to screen patients diagnosed with portal cavernoma, biliary atresia, cystic fibrosis, and other fibrotic chronic liver diseases with suspected portal hypertension. In cases of grade 2 varices with red marks and grade 3 varices >90% of centres perform sclerotherapy or endoscopic variceal ligation. Noncardioselective beta-blockers were used by approximately 20% of centres. In conclusion, despite the absence of scientific recommendations there is a tacit consensus concerning the need to screen children with clinical signs of portal hypertension, and to provide primary prophylaxis in cases of endoscopic patterns of high-risk varices.
儿童门静脉高压的一级预防存在争议,因为很少有研究证明其对出血风险的疗效。我们联系的38个中心中有28个中心返回了一份关于其临床实践的完整问卷。超过75%的中心使用内镜检查来筛查被诊断为门静脉海绵样变性、胆道闭锁、囊性纤维化和其他疑似门静脉高压的纤维化慢性肝病患者。在有红色征的2级静脉曲张和3级静脉曲张的病例中,>90%的中心进行硬化治疗或内镜下静脉曲张结扎术。约20%的中心使用非选择性β受体阻滞剂。总之,尽管缺乏科学建议,但对于筛查有门静脉高压临床体征的儿童以及对高危静脉曲张内镜表现的病例进行一级预防,存在一种默契的共识。